Presentations

Presenting our progress and vision

Nov 13, 2025

CTOS 2025 Annual Meeting – EFTISARC-NEO trial with neoadjuvant eftilagimod alfa (Soft Tissue Sarcoma)

Oct 29, 2025

Immutep Corporate Presentation

Oct 19, 2025

ESMO Congress 2025 – EFTISARC-NEO (Soft Tissue Sarcoma)

Oct 18, 2025

ESMO Congress 2025 – INSIGHT-003 (First Line Non-Small Cell Lung Cancer)

Oct 18, 2025

ESMO Congress 2025 – TACTI-004 (First Line Non-Small Cell Lung Cancer)